Peter Saitta is a Dermatology physician affiliated with New York University. OpenAlex indexes 15 publications with 238 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7901 4th Ave
Medical Education Suite
Brooklyn, NY 112093972
Telephone
718-491-5800Registry record last updated 19 Nov 2015.
Industry payments
35 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202528 payments
- SUN PHARMACEUTICAL INDUSTRIES INC.Program year202521 payments
- Janssen Biotech, Inc.Program year202519 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
70.2%Porphyrin Precursor69.3%Aminolevulinic acid hcl100%Part B, office-administered≥14 patientsInterleukin-23 Antagonist0.3%Skyrizi Pen100%Part D≥11 patients+ 2 more classes in this area
Dermatology
15.1%Corticosteroid14.1%Triamcinolone acetonide87%Triamcinolone Acetonide11%Halobetasol Propionate1%Fluocinolone Acetonide1%Part D + Part B<11 patientsInterleukin-4 Receptor alpha Antagonist0.3%Dupixent Pen100%Part D<11 patients+ 4 more classes in this area
Anti-infectives
4.8%Azole Antifungal2.3%Ketoconazole93%Fluconazole7%Part D<11 patientsTetracycline-class Drug0.8%Doxycycline Hyclate100%Part D≥44 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Frostbite on the hand of a homeless man.
PubMed
2014 - Is there a true concern regarding the use of hair dye and malignancy development?: a review of the epidemiological evidence relating personal hair dye use to the risk of malignancy.
PubMed
2013 - A Four-question Approach to Determining the Impact of Acne Treatment on Quality of Life.
PubMed
2012
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Galetta, MD
New York University
Herbert Lepor, MD
New York University
Aasma Shaukat, MD
New York University
Jerry Shapiro, MD
New York University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”